VVOS Stock | | | USD 4.55 0.06 1.30% |
Vivos Therapeutics financial indicator trend analysis is much more than just breaking down Vivos Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vivos Therapeutics is a good investment. Please check the relationship between Vivos Therapeutics Other Current Liab and its Current Deferred Revenue accounts. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Vivos Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in persons.
For more information on how to buy Vivos Stock please use our
How to Invest in Vivos Therapeutics guide.
Other Current Liab vs Current Deferred Revenue
Other Current Liab vs Current Deferred Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Vivos Therapeutics Other Current Liab account and
Current Deferred Revenue. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Vivos Therapeutics' Other Current Liab and Current Deferred Revenue is 0.83. Overlapping area represents the amount of variation of Other Current Liab that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Vivos Therapeutics, assuming nothing else is changed. The correlation between historical values of Vivos Therapeutics' Other Current Liab and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Liab of Vivos Therapeutics are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Other Current Liab i.e., Vivos Therapeutics' Other Current Liab and Current Deferred Revenue go up and down completely randomly.
Correlation Coefficient | 0.83 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Other Current Liab
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.
Most indicators from Vivos Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vivos Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Vivos Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in persons.
For more information on how to buy Vivos Stock please use our
How to Invest in Vivos Therapeutics guide.At this time, Vivos Therapeutics'
Issuance Of Capital Stock is comparatively stable compared to the past year.
Sales General And Administrative To Revenue is likely to gain to 1.85 in 2024, whereas
Selling General Administrative is likely to drop slightly above 21.8
M in 2024.
Vivos Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Vivos Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Vivos Therapeutics fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Vivos Stock Analysis
When running Vivos Therapeutics' price analysis, check to
measure Vivos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos Therapeutics is operating at the current time. Most of Vivos Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Vivos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos Therapeutics' price. Additionally, you may evaluate how the addition of Vivos Therapeutics to your portfolios can decrease your overall portfolio volatility.